Polymers for drug eluting stents

T Parker, V Dave, R Falotico - Current pharmaceutical design, 2010 - ingentaconnect.com
Currently approved drug eluting stents (DES) consist of a metallic scaffold and an elutable
drug dispersed in a polymer matrix that conformally surrounds the struts. These primarily …
被引用次数：58 相关文章

[引用][C] Polymers for Drug Eluting Stents

T PARKER, V DAVE… - Current pharmaceutical …, 2010 - pascal-francis.inist.fr
Polymers for Drug Eluting Stents CNRS Inist Pascal-Francis CNRS Pascal and Francis
Bibliographic Databases Simple search Advanced search Search by classification Search …

Polymers for drug eluting stents

T Parker, V Davé, R Falotico - Current pharmaceutical …, 2010 - pubmed.ncbi.nlm.nih.gov
Currently approved drug eluting stents (DES) consist of a metallic scaffold and an elutable
drug dispersed in a polymer matrix that conformally surrounds the struts. These primarily …

Polymers for Drug Eluting Stents

T Parker, V Dave, R Falotico - Current Pharmaceutical Design, 2010 - hero.epa.gov
Currently approved drug eluting stents (DES) consist of a metallic scaffold and an elutable
drug dispersed in a polymer matrix that conformally surrounds the struts. These primarily …

Polymers for drug eluting stents.

T Parker, V Davé, R Falotico - Current Pharmaceutical Design, 2010 - europepmc.org
Currently approved drug eluting stents (DES) consist of a metallic scaffold and an elutable
drug dispersed in a polymer matrix that conformally surrounds the struts. These primarily …

[引用][C] Polymers for Drug Eluting Stents

T PARKER, V DAVE, R FALOTICO - Current pharmaceutical design, 2010 - Bentham